Rino Rappuoli is Chief Scientist and Head of External R&D for GSK Vaccines. He is a professor of Vaccines Research at Imperial College London. Dr. Rappuoli has been elected a member of the U.S. National Academy of Sciences, the European Molecular Biology Organisation, and the Royal Society of London.
Moreover, he has received many national and international honours, among which the Gold Medal of the President of the Republic, Galeno Prize, Antonio Feltrinelli Prize, Paul Ehrlich and Ludwig Darmstaedter Prize, Albert B. Sabin Gold Medal, Canada Gairdner International Award, European Inventor Award for Lifetime Achievement, and Robert Koch Award.
He has long worked on the development of vaccines against serious diseases of viral or bacterial origin. Dr. Rappuoli developed and implemented various ideas and innovative techniques that have led to vaccines against pertussis, diphtheria, influenza, and meningococcal B and C, among other diseases. He is active in the scientific movement for sustainable global health.
He founded the GSK Vaccines Institute for Global Health, an institute headquartered in Siena that develops vaccines for poor countries.